GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Minibeam Radiation Therapy Enhanced Delivery of Nanoparticle Anticancer Agents to Pancreatic Cancer Tumors

$569,509
William C Zamboni · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA

Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment

$569,405
Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer

$569,381
Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA

Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity

$569,307
Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2024 · CA

Advancing Precision Oncology in a Humanized, Fully Autologous Mouse Model

$569,047
Ryan C Fields · Washington University · R01 · FY2024 · CA

New Tools for Prostate Cancer Detection and Prognostication

$568,800
Sanjiv S Gambhir · Stanford University · U01 · FY2010 · CA

Development and Application of a Porcine Model of Pancreatic Cancer

$568,591
Mark A Carlson · University Of Nebraska Medical Center · R01 · FY2018 · CA

Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens

$568,413
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA

New Therapuetics for Pancreatic Cancer

$568,413
Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · R01 · FY2024 · CA

Precision Therapy to Target Pancreatic Ductal Adenocarcinoma

$568,383
Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Chromatin Organization and RNA silencing

$568,312
Elissa Lei · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK

Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer

$567,785
Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2021 · CA

In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy

$567,432
Konstantin V Sokolov · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA

PROFILING SIGNALING ACTIVITY AND GENE EXPRESSION IN SINGLE, PANCREATIC ADENOCARCINOMA CELLS USING CE-RNA-SEQ

$567,412
Nancy L Allbritton · University Of Washington · R01 · FY2022 · CA

Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer

$567,204
Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2024 · CA

THE EARLY DETECTION OF PANCREATIC CANCER IN THE U.S. MILITARY

$566,797
Cold Spring Harbor Laboratory · · FY2014 · Department of the Army

Characterizing the sources, mechanisms, and translational relevance of microbial TMAO in driving anti-tumor immunity in pancreatic cancer.

$566,752
Rahul Suresh Shinde · Wistar Institute · R37 · FY2025 · CA

Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications

$566,567
Irving C Allen · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · CA

Multimodal AI Fusion Model for Early Detection for Pancreatic Cancer

$566,529
Imon Banerjee · Mayo Clinic Arizona · R01 · FY2025 · CA

Strategies for Therapeutic Cancer Vaccine Clinical Trials

$566,341
Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Nanovaccine platforms to combat pancreatic cancer

$566,261
Balaji Narasimhan · Iowa State University · U01 · FY2017 · CA

Digital Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples

$566,198
Tony Y. Hu · Tulane University Of Louisiana · U01 · FY2023 · CA

Multiplexed imaging of biliary intra-epithelial neoplasia

$566,133
Eric J Seibel · University Of Washington · R01 · FY2015 · CA

Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response

$566,131
Jeremiah Allen Johnson · Massachusetts Institute Of Technology · R01 · FY2024 · CA

Apoptosis Inducing to Enhance Tumor Targeting

$565,979
Ze Lu · Optimum Therapeutics, Llc · R44 · FY2007 · CA